Cellectis S.A. (CMVLF)
OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
| Previous close | 2.6000 |
| Open | 2.9600 |
| Bid | 1.9700 x 40000 |
| Ask | 2.6200 x 40000 |
| Day's range | 2.9600 - 2.9600 |
| 52-week range | 0.9500 - 3.5800 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 254.239M |
| Beta (5Y monthly) | 3.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Regenxbio (RGNX) Surges 18.3%: Is This an Indication of Further Gains?
Regenxbio (RGNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Zacks
Down -22.78% in 4 Weeks, Here's Why You Should You Buy the Dip in Cellectis (CLLS)
Cellectis (CLLS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- Zacks
Cellectis (CLLS) Upgraded to Buy: Here's Why
Cellectis (CLLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
© 2024 Yahoo. All rights reserved.